Overview

Regenerative Medicine Market Introduction

Global Regenerative Medicine Market is estimated to value over USD 39.1 billion by 2027 end and register a CAGR of over 22.7% during the forecast period 2020 to 2027.

A growing emphasis on stem cells and increasing research and development activities in developing nations are predicted to boost the global market growth. The emerging economies are focused on advancements in technology, which is predicted to propel market proliferation worldwide. Although, high treatment costs using regenerative medicine, strict regulations by the government and inefficiency in various operations and are projected to impede the market growth.

The dermatology segment dominated the dominate with respect to the generation of revenue in 2018. This subjugation can be credited to this largest global regenerative medicine market share that includes the easy availability of grafting methods for treating skin wounds and diseases. A substantial number of Food and Drug Administration (FDA) approved products for healing wounds are available for clinical applications over the last ten years.

Additionally, different advanced approaches in initial phases of development endorse tissue engineering. This includes the usage of drug delivery systems and biomaterials, which influence the replication of cells and control and stimulate the immune system. Increased complications of the process of wound healing with adverse diseases, for instance, HIV and diabetes have motivated research and development activities assisting the segment growth.

Major players equipped with novel technologies provide manufacturing, management, engineering, quality control services and characterization along with other facilities for researches related to the development of therapies of regeneration and clinical trials. Therefore, with a rise in clinical trials and research and development activities of regenerative medicines, the services segment is predicted to exhibit growth at a soaring rate.

Key market players included in the global regenerative medicine industry are Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Spark Therapeutics, Osiris Therapeutics, Kite Pharma, Organogenesis.

regenerative medicines market

Market Segmentation:

By Type

Cell-Based Immunotherapy & Cell Therapy Products
Allogeneic Products
Autologous Products
Tissue-Engineered Products
Gene Therapy Products

By Application

Musculoskeletal Disorders
Wound Care
Oncology
Ocular Disorders
Diabetes
Other Applications

By Region

North America
Europe
Asia Pacific
Rest of the World

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global regenerative medicine market by type, by application and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies